Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery. Ann Surg Oncol 2023 Mar;30(3):1305-1308
Date
12/09/2022Pubmed ID
36479662Pubmed Central ID
PMC9734328DOI
10.1245/s10434-022-12916-zScopus ID
2-s2.0-85143492422 (requires institutional sign-in at Scopus site) 3 CitationsAuthor List
Verhagen NB, Koerber NK, Szabo A, Taylor B, Wainaina JN, Evans DB, Kothari AN, N3C ConsortiumAuthors
Douglas B. Evans MD Chair, Professor in the Surgery department at Medical College of WisconsinAnai N. Kothari MD Assistant Professor in the Surgery department at Medical College of Wisconsin
Aniko Szabo PhD Professor in the Institute for Health and Equity department at Medical College of Wisconsin
Bradley W. Taylor Chief Research Informatics Officer in the Clinical and Translational Science Institute department at Medical College of Wisconsin
Jane N. Wainaina MD Vice Chair, Associate Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
HumansNeoplasms
Patients
Vaccination